Comparative efficacy of levosimendan and dobutamine in sepsis-related cardiac impairment: a meta-analysis [0.03%]
比较左西孟丹与多巴胺治疗脓毒症相关心脏功能障碍的疗效：一项系统综述和meta分析
Xiuwen Liu,Zakari Shaibu,Xinxiang Huang et al.
Xiuwen Liu et al.
Background: Sepsis-induced cardiac dysfunction significantly impacts patient outcomes, with inotropic support playing a crucial role in management. Levosimendan and dobutamine are commonly used, but their comparative effi...
The use of generic versus brand names in (clinical) pharmacology education across Europe: a cross-sectional survey [0.03%]
欧洲临床药学教育中通用名和商标名使用情况的横断面调查
Veronika Slezáková,Jitka Rychlíčková,Yoann Cazaubon et al.
Veronika Slezáková et al.
Purpose: In pharmacology and clinical pharmacology (P&CP) teaching, using generic names of medicines contributes to global comprehensibility. However, brand names are often used in routine clinical practice, which may pos...
Association between magnesium sulfate administration and mortality in critically ill patients with sepsis-associated acute kidney injury: a retrospective propensity score-matched cohort study [0.03%]
硫酸镁的使用与脓毒症相关急性肾损伤重症患者死亡率的关系：倾向性评分匹配队列研究
Xiang-Jie Duan,Jing-Ru Lan,Ming-Gao Zhu et al.
Xiang-Jie Duan et al.
Bleeding risk of rivaroxaban and edoxaban with and without amiodarone in atrial fibrillation patients: a prospective cohort study [0.03%]
利伐沙班和艾多沙班联合胺碘酮与房颤患者出血风险：前瞻性队列研究
Zi Wang,Fan Yang,Qiming Wang et al.
Zi Wang et al.
CYP2C19 genotyping and mavacamten: predicting outcomes in normal, intermediate and rapid metabolisers in obstructive hypertrophic cardiomyopathy [0.03%]
CYP2C19基因分型和mavacamten：在梗阻性肥厚型心肌病中预测正常代谢者、中间代谢者和快速代谢者的结局
Yande Kasolo,Edward Burford,Mohammed Obeidat et al.
Yande Kasolo et al.
Purpose: Mavacamten is the first targeted therapy for obstructive hypertrophic cardiomyopathy (oHCM). It is metabolised via cytochrome p450 enzymes, with variations in the CYP2C19 gene having predominant influence on plas...
Clopidogrel versus aspirin monotherapy following dual antiplatelet therapy after percutaneous coronary intervention: an updated meta-analysis of 162,829 patients [0.03%]
PCI术后氯吡格雷与阿司匹林单药治疗的Meta分析：基于162,829患者的分析更新
Mohammed A Elbahloul,Ahmed Mansour,Amr Galal et al.
Mohammed A Elbahloul et al.
Background: Dual antiplatelet therapy (DAPT) following percutaneous coronary intervention (PCI) remains a cornerstone for preventing ischemic events; however, the optimal long-term single antiplatelet therapy after comple...
Impact of policy measures targeting benzodiazepines and Benzodiazepine-related drugs in Lithuania: interrupted time series analysis [0.03%]
立陶宛针对苯二氮卓类和苯二氮卓相关药物的政策措施的影响：中断时间序列分析
Tomas Lasys,Sharon C M Essink,Yared Santa-Ana-Tellez et al.
Tomas Lasys et al.
Purpose: Prescribing recommendations, communication programmes, and mandatory electronic prescribing were implemented in Lithuania to promote responsible use of benzodiazepines and benzodiazepine-related drugs (BZRDs). We...
Early albumin infusion and mortality in ICU patients with HFpEF: a target trial emulation study [0.03%]
早期白蛋白输注与ICU心衰患者死亡率：靶向试验模拟研究
Zhen Wang,Meng-Li Li,Nin-Jun Zhu et al.
Zhen Wang et al.
Achilleas Livieratos,Ioannis Grigoropoulos,Sotirios Tsiodras
Achilleas Livieratos
The phenprocoumon echo: Elevated INR risk after VKA reversal - A retrospective analysis of phenprocoumon and acenocoumarol in clinical practice in a Dutch teaching hospital [0.03%]
酚 procoumon 回声：在荷兰教学医院临床实践中的维生素 K 拮抗剂逆转后国际正常化比率升高风险-酚 procoumon 和醋硝香豆素的回顾性分析
Emma M C Tijmensen-Reijers,Soha Saleh,Anita Griffioen-Keijzer et al.
Emma M C Tijmensen-Reijers et al.